Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-27
2000-04-18
Trinh, Ba K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549510, 549511, A61K 31335, C07D30514
Patent
active
060516003
ABSTRACT:
Provided herein is a taxane having a hydrocarbon attached at the 2' and/or 7 positions, the hydrocarbon's alpha position being occupied by a "hydrolysis-promoting group" ("HPG"). Substitution of an HPG for the methylene unit ordinarily occupying the alpha position allows for enhanced in vivo hydrolysis of the hydrocarbon-taxane bond, and hence, for enhanced taxane therapeutic activity. Also provided herein are taxane-containing compositions, and methods of administering taxanes to animals, including those afflicted with cancers.
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4837028 (1989-06-01), Allen
patent: 4920016 (1990-04-01), Allen et al.
patent: 4960760 (1990-10-01), Stella et al.
patent: 4975282 (1990-12-01), Cullis et al.
patent: 5008050 (1991-04-01), Cullis et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5015744 (1991-05-01), Holton
patent: 5030453 (1991-07-01), Lenk et al.
patent: 5059699 (1991-10-01), Kingston et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5169637 (1992-12-01), Lenk et al.
patent: 5200534 (1993-04-01), Rao
patent: 5278324 (1994-01-01), Kingston et al.
patent: 5534499 (1996-07-01), Ansell
Bangham, et al., "Diffusion of univalent Ions across the Lamellae of Swollen Phospholipids" J. Mol. Biol. 13:238-252, 1965.
Blume, et al., "Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to ends of thr polymeric chains compbines effective target binding with long circulation times", BBA 1149:180 (1993).
Borman, "Scientists Mobilize to Increase Supply of Anticancer Drug Taxol", Chemical & Engineering News, Sep. 2, 1991, p. 11-18.
Deamer, et al., Liposome Preparation: Methods and Mechanisma,. in Liposomes (M. Ostro, ed.,)Marcel Dekker, Inc., New York, (1983), pp. 27-52.
Edgington, "Taxol, out of the words", Biotechnology 9:933-938 (Oct. 1991).
Gabizon, et al., "Prologation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polytheylene Glyco-Derivatized Phospholipid: Pharmacokinetc Studies in Rodents and Dogs", Pharm Res., 10(5):703 (1993).
Holton, et al., "First Total Synthesis of Taxol. 1. Functionalization of the B Ring", J. Am. Chem. Sos. 116:1597-1600, (1994).
Narin, "Solutions, Emulsions, suspensions and Extractives" in:Remington's Pharmacetuical Science (A. Gennaro, ed.,) Mack Publishing Co., Easton, PA (1985), pp. 1492-1517.
Nicolau, "Design, systhesis and biological activity of protaxols", Nature, 364, 464-466, 1993.
Nicolau, "Total synthesis of taxol", Nature, 367 (1994) 630-634.
Park et al., "Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo", BBA 1108:257 (1992).
Rizzo, et al., "Analysis of anitcancer drugs in biological gluids: determination of taxol with application to clinical pharmacodinetics", J. Pharm & Biomed. Anal, 8(2):159-164 (1990).
Schiff, et al., "Promotion of microtubule assembly in vitro by taxol", Nature 277:665 (1979).
Suffness, Antitumor Alkaloids, in: "The Alkalodis, vol. XXV", Academic Press, Inc. (1985), Chapter 1, pp. 6-18.
The Pharmacological Basis of Therapeutics (Goodman Filman, et al., eds.,) Pergamon press, New York (1990), p. 1239.
Ali Shaukat
Janoff Andrew S.
Mayhew Eric
LandOfFree
Liposomal hydrolysis-promoting hydrophobic taxane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposomal hydrolysis-promoting hydrophobic taxane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal hydrolysis-promoting hydrophobic taxane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336717